Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by princeofcuton Jul 24, 2015 9:36am
61 Views
Post# 23956058

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:and meanwhile back in china hepa is still not trading...

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:and meanwhile back in china hepa is still not trading...
four,

re. noncompliance...IME as soon as any babybiotech wonders into 3rd world countries (Eastern Europe very, very, very bad) sponsors should expect trial failure just based on non-compliance and other things...don't know where ASSURE went for trials ..i made a lot of money when cowtown doncyltics did a mid trial expansion into Eastern Europe i then predicted failure and invested accordingly and the trial failed...

re. founders IMO Smelnyk is a criminal and is never spoken of as a success the trading scam he constructed was stunning in its complexity to steal (imagine having your personal lawyer on your BoD and then as head of your blind family trust that was HQ'ed in the Caymans (or some similar cowpature) and then frontrunning and trading Biovail based on non-public info)...it speaks to and frames my basic position on all founders in Canada...

..anyways the only rock star was the fellow (Italian name) who developed the first AIDS vaccine and i believe the current CEO of TTH was part of that team... but none-the-less Canada has almost no one
Bullboard Posts